Case File
efta-02518286DOJ Data Set 11OtherEFTA02518286
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02518286
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Tuesday, March 18, 2014 12:03 AM
To:
Tazia Smith
Subject:
Re: First BRL note valuation date 3/20, poised to settle beyond barrier (down -20%)
(CI
is there a number ???
=br>
On Mon, Mar 17, 2014 at 1:44 PM, Tazia S=ith ste
> wrote:
Classification: Co=fidential
Jeffrey -
First BRL note's valuation date is this Thursday, 3/20 (settles 3/27); presently down 19.8%, intrinsic. Your
original investment was $1mm notional.
Initial strike:
1.9619
15% european barrier:
2.2562
Current USDBRL spot:
2.3505
Your second note has a final valuation of 4/14. Initial strike 2.0035, european barrier =2.3040.
Recall that the payout on these was as follows:
a) make 28.5% if BRL is up more than 3% vs. USD at maturity, b) make 5% if BRL is up between 0-3% vs USD, c)
get your principal down less than 15% vs. USD, d) loose 1 for 1 if BRL is down more than 15% vs USD at maturity (max
loss 100%)
Used with permission of Bloomberg Finance LP
Tazia Smith
Director Key Client Partners - US
EFTA_R1_01653850
EFTA02518286
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communicational> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of thear> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this commun=cation is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01653851
EFTA02518287
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.